Eversept Partners’s Magellan Health Services, Inc. MGLN Stock Holding History

Eversept Partners’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-104,700	Closed	-$9.95M	–	117
2021 Q4	$9.95M	Hold	104,700	–	–	0.64%	42
2021 Q3	$9.9M	Hold	104,700	–	–	0.68%	39
2021 Q2	$9.86M	Hold	104,700	–	–	0.66%	37
2021 Q1	$9.76M	Hold	104,700	–	–	0.73%	38
2020 Q4	$8.67M	Buy	+104,700	New	+$8.28M	1.02%	27
2018 Q3	–	Sell	-3,000	Closed	-$288K	–	80
2018 Q2	$288K	Sell	3,000 -6,282	-68%	-$602K	0.13%	68
2018 Q1	$994K	Hold	9,282	–	–	0.46%	38
2017 Q4	$896K	Buy	+9,282	New	+$821K	0.52%	32

Eversept Partners's MGLN Position: Q1 2022 in Review

Eversept Partners sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 104,700 shares — an estimated $9.95M sold.

Eversept Partners first reported a position in MGLN in Q4 2017 and held it in 8 quarters. The position peaked at $9.95M in Q4 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

Eversept Partners reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
Eversept Partners sold 104,700 Magellan Health Services, Inc. shares in Q1 2022, an estimated $9.95M.
Eversept Partners first reported a position in Magellan Health Services, Inc. in Q4 2017 and held it in 8 quarters.
Eversept Partners's Magellan Health Services, Inc. position peaked at $9.95M in Q4 2021.
0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Eversept Partners's 13F filing for Q1 2022, filed 16 May 2022.